Solventum Co. (NYSE:SOLV) Receives Average Recommendation of “Hold” from Analysts

Shares of Solventum Co. (NYSE:SOLVGet Free Report) have earned a consensus rating of “Hold” from the eleven ratings firms that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, nine have assigned a hold recommendation and one has assigned a buy recommendation to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $79.86.

SOLV has been the topic of several research analyst reports. Wells Fargo & Company raised their price target on shares of Solventum from $73.00 to $75.00 and gave the stock an “equal weight” rating in a research report on Friday, February 28th. Piper Sandler lifted their target price on Solventum from $75.00 to $84.00 and gave the stock a “neutral” rating in a research report on Friday, February 28th. Bank of America upped their price target on Solventum from $80.00 to $85.00 and gave the company a “neutral” rating in a report on Wednesday, February 26th. Morgan Stanley lifted their price objective on Solventum from $73.00 to $80.00 and gave the stock an “equal weight” rating in a report on Wednesday, March 5th. Finally, Mizuho upped their target price on Solventum from $70.00 to $82.00 and gave the company a “neutral” rating in a research note on Monday, March 3rd.

Read Our Latest Stock Report on Solventum

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. Modus Advisors LLC acquired a new position in Solventum in the fourth quarter worth $25,000. Clarity Asset Management Inc. bought a new stake in Solventum during the 4th quarter worth about $25,000. Stonebridge Financial Group LLC acquired a new stake in Solventum in the 4th quarter valued at about $26,000. Raiffeisen Bank International AG bought a new position in shares of Solventum in the fourth quarter worth about $29,000. Finally, Crews Bank & Trust acquired a new position in shares of Solventum during the fourth quarter worth approximately $32,000.

Solventum Stock Up 0.9 %

SOLV opened at $74.87 on Wednesday. The business has a 50 day moving average of $75.38 and a 200-day moving average of $71.73. The stock has a market capitalization of $12.95 billion and a price-to-earnings ratio of 27.23. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45. Solventum has a 1-year low of $47.16 and a 1-year high of $85.92.

About Solventum

(Get Free Report

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.

Featured Stories

Analyst Recommendations for Solventum (NYSE:SOLV)

Receive News & Ratings for Solventum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solventum and related companies with MarketBeat.com's FREE daily email newsletter.